Global Embolotherapy Market Forecast to 2028

The global embolotherapy market size reached USD 3.50 Billion in 2020 and is expected to register a revenue CAGR of 9.3%, during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of chronic diseases such as cancer, peripheral artery disease, and neurological disorders among others is a key factor driving global embolotherapy market revenue growth. Steady transition towards minimally invasive procedures from invasive open surgical procedures is expected to continue to drive revenue growth of the global embolotherapy market. Increasing demand for image-guided minimally invasive interventions have not only broadened the scope of vascular pathologies that can be treated, but has also resulted in reduction of post-operative morbidity compared to open surgical techniques.  Embolization is an advanced form of treatment option whereby tiny equipment is used to navigate the body’s vasculature without the need for using wound incision or open surgery. This enables reduced complication rates, increases success rate, and improves quality of life of patients.

Forecasts for the Embolotherapy market have been offered by the report's writers, along with qualitative and quantitative analyses. The SWOT analysis and Porter's Five Forces Analysis are two of the most crucial sections of this study since they shed light on the fiercely competitive environment of the sector. North America, Europe, Latin America, Asia Pacific, the Middle East, and Africa are all included in the report's in-depth research of the global Embolotherapy market. Together with revenue growth drivers, limitations, production consumption patterns, shifting consumer tastes, and strict regulatory standards, this research also looks at other important features of regional markets.

Request a Sample Report with Table of Contents and Figures to visit this site @ https://www.emergenresearch.com/request-sample/763

Competitive Terrain:

The global Embolotherapy industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Terumo Medical Corporation, Penumbra Inc., Johnson & Johnson, Merit Medical Systems Inc., Cook Medical Inc., Kaneka Corporation, and Stryker Corporation

Research Report on the Embolotherapy Market Addresses the Following Key Questions:

  • Who are the dominant players of the Embolotherapy market?
  • Which regional market is anticipated to have a high growth rate over the projected period?
  • What consumer trends and demands are expected to influence the operations of the market players in the Embolotherapy market?
  • What are the key growth drivers and restraining factors of the Embolotherapy market?
  • What are the expansion plans and strategic investment plans undertaken by the players to gain a robust footing in the market?
  • What is the overall impact of the COVID-19 pandemic on the Embolotherapy market and its key segments?

Market Overview:

The report bifurcates the Embolotherapy market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.

Segments Covered in this report are:

  • Product Outlook (Revenue, USD Billion; 2018–2028)
    • Embolic Agents
      1. Liquid Embolic Agents
      2. Microspheres
    • Embolization Coils
      1. Detachable Coils
      2. Pushable Coils
    • Detachable Balloons
    • Embolic Plug Systems
    • Support Devices
      1. Microcatheters
      2. Guidewires
  • Procedure Outlook (Revenue, USD Billion; 2018–2028)
    • Transcatheter Arterial Embolization
    • Transcatheter Arterial Radioembolization
    • Transcatheter Chemoembolization
  • Application Outlook (Revenue, USD Billion; 2018–2028)
    • Cancer
    • Peripheral Vascular Disease
    • Neurological Disease
    • Urological & Nephrological Disorders
    • Others

Regional Landscape section of the Embolotherapy report offers deeper insights into the regulatory framework, current and emerging market trends, production and consumption patterns, supply and demand dynamics, import/export, and presence of major players in each region.

The various regions analyzed in the report include:

  • North America (U.S., Canada)
  • Europe (U.K., Italy, Germany, France, Rest of EU)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/embolotherapy-market

Some Key Highlights from the Report

  • Embolic agents segment is expected to account for largest revenue share over the forecast period due to increasing use of calibrated microscopes, biodegradable microspherical embolic agents and increasing development of next generation liquid embolics for facilitating treatment of a variety of pathological disease.
  • Transcatheter arterial radioembolization segment revenue is expected to expand at a rapid CAGR over the forecast period owing to rising popularity of this therapeutic modality for effectively treating both primary and secondary hepatobilary disease and increasing investment to develop next generation radioembolic devices to improve clinical outcomes.
  • Cancer segment is expected to account for largest revenue share over the forecast period owing to rising prevalence of liver cancer and increasing number of transarterial chemoembolization procedures performed for controlling tumor growth and destroying cancer cells and providing quality care to patients suffering with liver cancer.
  • Ambulatory surgical segment is expected to register a significantly robust CAGR in terms of revenue over the forecast period due to increasing preference for outpatient surgical procedures, increasing patient admissions in these facilities, availability of reimbursement, and increasing number of embolotherapy surgical procedures performed at these facilities.
  • North America is expected to account largest revenue share over the forecast period due to rising number of clinical trials for assessing safety and efficacy of embolization in a wide range of applications and increasing use of Drug-Elating Bead Transarterial Chemoembolization (DEB-TACE)

The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Embolotherapy market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.

Key Points of the Geographical Analysis:

  • Data and information related to the consumption rate in each region
  • Estimated increase in the consumption rate
  • Proposed growth of the market share of each region
  • Geographical contribution to market revenue
  • Expected growth rate of the regional markets

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/763

Thank you for reading our report. To know more about the customization feature, please get in touch with us, and our team will ensure the report is customized to meet your requirements.  

Latest Published Articles by Emergen Research:

electric vehicle ecu market         

https://www.emergenresearch.com/industry-report/electric-vehicle-ecu-market

agriculture surfactants market  

https://www.emergenresearch.com/industry-report/agriculture-surfactants-market

5g networks market      

https://www.emergenresearch.com/industry-report/5g-networks-market

ai-based sensors market              

https://www.emergenresearch.com/industry-report/ai-based-sensors-market

heart rhythm devices market     

https://www.emergenresearch.com/industry-report/heart-rhythm-devices-market

metastatic urothelial carcinoma market

https://www.emergenresearch.com/industry-report/metastatic-urothelial-carcinoma-market

cancer tumor profiling market   

https://www.emergenresearch.com/industry-report/cancer-tumor-profiling-market

deep neural networks market   

https://www.emergenresearch.com/industry-report/deep-neural-networks-market

pharmacogenomics market        

https://www.emergenresearch.com/industry-report/pharmacogenomics-market

air purifier market          

https://www.emergenresearch.com/industry-report/air-purifier-market

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Latest Report: Sleep Apnea Devices MarketSurgical Sutures Market

Trending Title: Fecal Transplant Therapy MarketHereditary Genetic Testing Market